GeneTex is featured in a new Nature Protocols publication for our collaboration with YCharOS to improve antibody validation and research reproducibility. Read more about how we’re advancing antibody quality here: https://lnkd.in/gbBrZdTn
关于我们
As a multinational antibody manufacturer, GeneTex’s primary goal is to provide bioscience researchers with thoroughly validated reagents to accelerate their discovery. Established in 1997 in San Antonio, Texas by scientists with expertise in clinical oncology, cancer biology, and infectious disease, the company’s initial focus was breast cancer biology and prognostic marker research. This evolved to incorporate a comprehensive portfolio of immunological reagents used by scientists probing the underlying mechanisms common to many forms of cancer. GeneTex’s catalog has since expanded to offer a broad and diverse selection of antibody products covering a full range of research areas. GeneTex is proud to offer the highest quality antibody reagents supported by extensive research, development, and validation. We are committed to the highest standards of product performance.
- 网站
-
https://www.genetex.com
GeneTex, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Irvine,CA
- 类型
- 私人持股
- 创立
- 1997
- 领域
- Antibodies for Biomedical Research、Immunoblotting Reagents、Ancillary Products for IHC, ICC/IF, ELISA, Flow Cytometry、Antibodies for Cancer Biology、DNA Repair、Virology/Infectious Disease、Cell Biology、Neuroscience、Immunology、Epigenetics和and Zebrafish Biology
地点
GeneTex, Inc.员工
动态
-
Please visit the GeneTex booth at the upcoming USCAP Annual Meeting in Boston, MA, March 22-27, 2025. We are excited to introduce our expanding line of HistoMAX™ monoclonal antibodies, all of which have been scrupulously validated for performance in immunohistochemistry (IHC) on human normal and neoplastic tissue arrays. GeneTex’s recombinant antibody facility produces over 1,000 clones a year. With this production capacity, we look forward to leading the way in new biomarker discovery. #USCAP #IHC #PATHOLOGY #ANTIBODIES
-
-
Join us for an exciting webinar presented by Dr. Savelkoul! Topic: Immunomodulation by food to maintain gastrointestinal health Dr. H.F.J. Savelkoul earned his Ph.D. in Immunology from Erasmus University and completed a postdoctoral fellowship at DNAX Research Institute. He progressed from Assistant to Associate Professor at Erasmus before becoming a Full Professor in Cell Biology and Immunology at Wageningen University. His research focuses on food-immune interactions, immunochemistry, and diagnostics, leading to nearly 400 publications, eight patents, and multiple awards, including recognition for teaching excellence. He has mentored over 50 Ph.D. candidates, co-edited books, and is an active member of prestigious immunology societies. Dr. Savelkoul’s webinar will highlight the role that nutrition and food (or its components) play in supporting intestinal immunological homeostasis to sustain health by discussing some examples from his own research. Register now via the link below! https://lnkd.in/gckYt7XW
-
-
GeneTex is pleased to welcome Mr. Jonas Baeuerle as Vice President EMEA to lead the company's European division. With over a decade of experience in the research antibody, reagent, and diagnostics distribution industry, Jonas brings a wealth of knowledge and expertise to the GeneTex executive team. "I am thrilled to join GeneTex. I have great respect for the company's underlying values of research-driven product development and discovery. I look forward to participating in GeneTex's next stage of development, and making a meaningful impact on the research community," said Jonas Baeuerle. "GeneTex benefited from the growth that Jonas achieved while managing Germany's largest life science distributor. We are excited to witness the expansion of the GeneTex brand under his leadership," said GeneTex President Allen Lee.
-
-
We are pleased to announce that the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) have supported our work: to provide researchers across the midlands with the data they need to adopt the most robust non-animal antibodies and affinity reagents. Thank you to the YCharOS Inc. collaborative for allowing us to utilise this excellent Open Science partnership to serve these communities. Hannah C. and Ravindran Kumaran at Abcam Christian Tiede at Affimer group Pierre Cosson at ABCD ABclonal Technology Aviva Systems Biology Bio-Techne Srikanth Subramanian and Katie Crosby at Cell Signaling Technology (CST) Douglas Houston at Developmental Studies Hybridoma Bank Alexander Ball, Jr. at GeneTex, Inc. Horizon Discovery Deepa Shankar at Proteintech Group Deborah Moshinsky, Ph.D. at Institute for Protein Innovation SYSY Antibodies Rachel Giesler, MBA at Thermo Fisher Scientific Also thanks to the Only Good Antibodies community team pictured, but also David Cousins; Adam Wright, Panayiota Stylianou, PhD; Malgorzata Rekas. https://lnkd.in/eVdtDARG
-
Super proud of our partners at The Neuro (Montreal Neurological Institute-Hospital), The Structural Genomics Consortium (SGC) and our manufacturer partners (listed below) for their recently published paper with Springer Nature in Nature Protocols. https://rdcu.be/d3RCV The paper formalizes our method for testing reagent antibodies side-by-side using genetic strategies. We're helping identify the best performing antibodies for research to help unlock cutting edge discoveries. Abcam ABclonal Technology Aviva Systems Biology Addgene Bio-Techne Cell Signaling Technology (CST) Developmental Studies Hybridoma Bank GeneTex, Inc. Proteintech Group Revvity Thermo Fisher Scientific
-
GeneTex, Inc. and Synaptic Systems GmbH RRIDs for your antibodies were used in "miRNA-mediated control of gephyrin synthesis drives sustained inhibitory synaptic plasticity." RRIDs are crucial for improving rigor and reproducibility in science! Read the full article: https://lnkd.in/gatrS_JG #antibody #antibodies
-
GeneTex, Inc. and Proteintech Group your antibodies were used in "ARF alters PAF1 complex integrity to selectively repress oncogenic transcription programs upon p53 loss" published in ScienceDirect! #antibodies #antibody Read more : https://lnkd.in/gbNTeEey
-
Citations and images for GeneTex antibodies are powered by CiteAb!
Scientific credibility and relevance of citation data displayed on product pages is crucial. We’ve recently shared a look at how our partner GeneTex, Inc. use our Citation Widget on their website to display infographics, published images and citations for their products. Discover how linking reagents to the specific applications they've been used in helps scientists find relevant information on their pages ⬇ https://lnkd.in/eUz4skMr
-
Nature Magazine just published an insightful piece on the reproducibility crisis in biomedical research, highlighting the role of RRIDs in helping address this critical issue. At SciCrunch Inc., we’re proud to support researchers by providing RRIDs as a tool to improve transparency and reproducibility in scientific studies. Many thanks to our antibody partners: Thermo Fisher Scientific, Bio-Techne, GeneTex, Inc., Proteintech Group, DSHB at the University of Iowa and Addgene who have joined us in this vital initiative. Together, we are setting a new benchmark for reliability in science. Learn more in the article, and see how RRIDs are changing the game for reproducibility! https://lnkd.in/eeed7a5P #RRIDs #ReproducibilityCrisis #ResearchIntegrity #TransparencyInScience #SciCrunch Cell Signaling Technology (CST), Abcam, Aviva Systems Biology ABclonal Technology, Bioss Inc., RayBiotech, antibodies-online.com, Assay Biotech Inc., Biorbyt, Immunoway Biotechnology, Abcepta, YntoAb, Hello Bio, EpigenTek, EnoGene Biotech Co. Ltd, Abbexa, Abcalis GmbH, Innovative Research, Standard BioTools